Click for best price
Clinical Trials Market Size, Share 2023
Market size in 2022 |
US$ 48020 million
|
Forecast Market size by 2029 |
US$ 63030 million
|
Growth Rate |
CAGR of 4.0% |
Number of Pages |
63 Pages |
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial ? their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
This report aims to provide a comprehensive presentation of the global market for Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trials. This report contains market size and forecasts of Clinical Trials in global, including the following market information:
Global Clinical Trials Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Clinical Trials market was valued at US$ 48020 million in 2022 and is projected to reach US$ 63030 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
We surveyed the Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Trials Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Phase I
Phase II
Phase III
Phase IV
Global Clinical Trials Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Interventional
Observational
Expanded Access
Global Clinical Trials Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Quintiles IMS
Paraxel International Corporation
Charles River Laboratories
ICON plc
SGS SA
Pharmaceutical Product Development, LLC
Wuxi AppTec Inc.
PRA Health Sciences
Chiltern International Ltd.
INC Research
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Trials, market overview.
Chapter 2: Global Clinical Trials market size in revenue.
Chapter 3: Detailed analysis of Clinical Trials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Trials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Report Attributes |
Report Details |
Report Title |
Clinical Trials Market, Global Outlook and Forecast 2023-2029 |
Market size in 2022 |
US$ 48020 million
|
Forecast Market size by 2029 |
US$ 63030 million
|
Growth Rate |
CAGR of 4.0% |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2022 |
Forecast Year |
2030 |
Number of Pages |
63 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Clinical Trials Overall Market Size
2.1 Global Clinical Trials Market Size: 2022 VS 2029
2.2 Global Clinical Trials Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Clinical Trials Players in Global Market
3.2 Top Global Clinical Trials Companies Ranked by Revenue
3.3 Global Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 Clinical Trials Companies in Global Market, by Revenue in 2022
3.5 Global Companies Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Trials Players in Global Market
3.6.1 List of Global Tier 1 Clinical Trials Companies
3.6.2 List of Global Tier 2 and Tier 3 Clinical Trials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Clinical Trials Market Size Markets, 2022 & 2029
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.1.5 Phase IV
4.2 By Type - Global Clinical Trials Revenue & Forecasts
4.2.1 By Type - Global Clinical Trials Revenue, 2018-2023
4.2.2 By Type - Global Clinical Trials Revenue, 2024-2029
4.2.3 By Type - Global Clinical Trials Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Clinical Trials Market Size, 2022 & 2029
5.1.2 Interventional
5.1.3 Observational
5.1.4 Expanded Access
5.2 By Application - Global Clinical Trials Revenue & Forecasts
5.2.1 By Application - Global Clinical Trials Revenue, 2018-2023
5.2.2 By Application - Global Clinical Trials Revenue, 2024-2029
5.2.3 By Application - Global Clinical Trials Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Clinical Trials Market Size, 2022 & 2029
6.2 By Region - Global Clinical Trials Revenue & Forecasts
6.2.1 By Region - Global Clinical Trials Revenue, 2018-2023
6.2.2 By Region - Global Clinical Trials Revenue, 2024-2029
6.2.3 By Region - Global Clinical Trials Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Clinical Trials Revenue, 2018-2029
6.3.2 US Clinical Trials Market Size, 2018-2029
6.3.3 Canada Clinical Trials Market Size, 2018-2029
6.3.4 Mexico Clinical Trials Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Clinical Trials Revenue, 2018-2029
6.4.2 Germany Clinical Trials Market Size, 2018-2029
6.4.3 France Clinical Trials Market Size, 2018-2029
6.4.4 U.K. Clinical Trials Market Size, 2018-2029
6.4.5 Italy Clinical Trials Market Size, 2018-2029
6.4.6 Russia Clinical Trials Market Size, 2018-2029
6.4.7 Nordic Countries Clinical Trials Market Size, 2018-2029
6.4.8 Benelux Clinical Trials Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Clinical Trials Revenue, 2018-2029
6.5.2 China Clinical Trials Market Size, 2018-2029
6.5.3 Japan Clinical Trials Market Size, 2018-2029
6.5.4 South Korea Clinical Trials Market Size, 2018-2029
6.5.5 Southeast Asia Clinical Trials Market Size, 2018-2029
6.5.6 India Clinical Trials Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Clinical Trials Revenue, 2018-2029
6.6.2 Brazil Clinical Trials Market Size, 2018-2029
6.6.3 Argentina Clinical Trials Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Clinical Trials Revenue, 2018-2029
6.7.2 Turkey Clinical Trials Market Size, 2018-2029
6.7.3 Israel Clinical Trials Market Size, 2018-2029
6.7.4 Saudi Arabia Clinical Trials Market Size, 2018-2029
6.7.5 UAE Clinical Trials Market Size, 2018-2029
7 Clinical Trials Companies Profiles
7.1 Quintiles IMS
7.1.1 Quintiles IMS Company Summary
7.1.2 Quintiles IMS Business Overview
7.1.3 Quintiles IMS Clinical Trials Major Product Offerings
7.1.4 Quintiles IMS Clinical Trials Revenue in Global Market (2018-2023)
7.1.5 Quintiles IMS Key News & Latest Developments
7.2 Paraxel International Corporation
7.2.1 Paraxel International Corporation Company Summary
7.2.2 Paraxel International Corporation Business Overview
7.2.3 Paraxel International Corporation Clinical Trials Major Product Offerings
7.2.4 Paraxel International Corporation Clinical Trials Revenue in Global Market (2018-2023)
7.2.5 Paraxel International Corporation Key News & Latest Developments
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Company Summary
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories Clinical Trials Major Product Offerings
7.3.4 Charles River Laboratories Clinical Trials Revenue in Global Market (2018-2023)
7.3.5 Charles River Laboratories Key News & Latest Developments
7.4 ICON plc
7.4.1 ICON plc Company Summary
7.4.2 ICON plc Business Overview
7.4.3 ICON plc Clinical Trials Major Product Offerings
7.4.4 ICON plc Clinical Trials Revenue in Global Market (2018-2023)
7.4.5 ICON plc Key News & Latest Developments
7.5 SGS SA
7.5.1 SGS SA Company Summary
7.5.2 SGS SA Business Overview
7.5.3 SGS SA Clinical Trials Major Product Offerings
7.5.4 SGS SA Clinical Trials Revenue in Global Market (2018-2023)
7.5.5 SGS SA Key News & Latest Developments
7.6 Pharmaceutical Product Development, LLC
7.6.1 Pharmaceutical Product Development, LLC Company Summary
7.6.2 Pharmaceutical Product Development, LLC Business Overview
7.6.3 Pharmaceutical Product Development, LLC Clinical Trials Major Product Offerings
7.6.4 Pharmaceutical Product Development, LLC Clinical Trials Revenue in Global Market (2018-2023)
7.6.5 Pharmaceutical Product Development, LLC Key News & Latest Developments
7.7 Wuxi AppTec Inc.
7.7.1 Wuxi AppTec Inc. Company Summary
7.7.2 Wuxi AppTec Inc. Business Overview
7.7.3 Wuxi AppTec Inc. Clinical Trials Major Product Offerings
7.7.4 Wuxi AppTec Inc. Clinical Trials Revenue in Global Market (2018-2023)
7.7.5 Wuxi AppTec Inc. Key News & Latest Developments
7.8 PRA Health Sciences
7.8.1 PRA Health Sciences Company Summary
7.8.2 PRA Health Sciences Business Overview
7.8.3 PRA Health Sciences Clinical Trials Major Product Offerings
7.8.4 PRA Health Sciences Clinical Trials Revenue in Global Market (2018-2023)
7.8.5 PRA Health Sciences Key News & Latest Developments
7.9 Chiltern International Ltd.
7.9.1 Chiltern International Ltd. Company Summary
7.9.2 Chiltern International Ltd. Business Overview
7.9.3 Chiltern International Ltd. Clinical Trials Major Product Offerings
7.9.4 Chiltern International Ltd. Clinical Trials Revenue in Global Market (2018-2023)
7.9.5 Chiltern International Ltd. Key News & Latest Developments
7.10 INC Research
7.10.1 INC Research Company Summary
7.10.2 INC Research Business Overview
7.10.3 INC Research Clinical Trials Major Product Offerings
7.10.4 INC Research Clinical Trials Revenue in Global Market (2018-2023)
7.10.5 INC Research Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Clinical Trials Market Opportunities & Trends in Global Market
Table 2. Clinical Trials Market Drivers in Global Market
Table 3. Clinical Trials Market Restraints in Global Market
Table 4. Key Players of Clinical Trials in Global Market
Table 5. Top Clinical Trials Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Clinical Trials Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Clinical Trials Revenue Share by Companies, 2018-2023
Table 8. Global Companies Clinical Trials Product Type
Table 9. List of Global Tier 1 Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Clinical Trials Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Clinical Trials Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Clinical Trials Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Clinical Trials Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 30. Quintiles IMS Company Summary
Table 31. Quintiles IMS Clinical Trials Product Offerings
Table 32. Quintiles IMS Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 33. Quintiles IMS Key News & Latest Developments
Table 34. Paraxel International Corporation Company Summary
Table 35. Paraxel International Corporation Clinical Trials Product Offerings
Table 36. Paraxel International Corporation Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 37. Paraxel International Corporation Key News & Latest Developments
Table 38. Charles River Laboratories Company Summary
Table 39. Charles River Laboratories Clinical Trials Product Offerings
Table 40. Charles River Laboratories Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 41. Charles River Laboratories Key News & Latest Developments
Table 42. ICON plc Company Summary
Table 43. ICON plc Clinical Trials Product Offerings
Table 44. ICON plc Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 45. ICON plc Key News & Latest Developments
Table 46. SGS SA Company Summary
Table 47. SGS SA Clinical Trials Product Offerings
Table 48. SGS SA Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 49. SGS SA Key News & Latest Developments
Table 50. Pharmaceutical Product Development, LLC Company Summary
Table 51. Pharmaceutical Product Development, LLC Clinical Trials Product Offerings
Table 52. Pharmaceutical Product Development, LLC Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 53. Pharmaceutical Product Development, LLC Key News & Latest Developments
Table 54. Wuxi AppTec Inc. Company Summary
Table 55. Wuxi AppTec Inc. Clinical Trials Product Offerings
Table 56. Wuxi AppTec Inc. Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 57. Wuxi AppTec Inc. Key News & Latest Developments
Table 58. PRA Health Sciences Company Summary
Table 59. PRA Health Sciences Clinical Trials Product Offerings
Table 60. PRA Health Sciences Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 61. PRA Health Sciences Key News & Latest Developments
Table 62. Chiltern International Ltd. Company Summary
Table 63. Chiltern International Ltd. Clinical Trials Product Offerings
Table 64. Chiltern International Ltd. Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 65. Chiltern International Ltd. Key News & Latest Developments
Table 66. INC Research Company Summary
Table 67. INC Research Clinical Trials Product Offerings
Table 68. INC Research Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 69. INC Research Key News & Latest Developments
List of Figures
Figure 1. Clinical Trials Segment by Type in 2022
Figure 2. Clinical Trials Segment by Application in 2022
Figure 3. Global Clinical Trials Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Clinical Trials Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Clinical Trials Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Clinical Trials Revenue in 2022
Figure 8. By Type - Global Clinical Trials Revenue Market Share, 2018-2029
Figure 9. By Application - Global Clinical Trials Revenue Market Share, 2018-2029
Figure 10. By Type - Global Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Clinical Trials Revenue Market Share, 2018-2029
Figure 12. By Application - Global Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Clinical Trials Revenue Market Share, 2018-2029
Figure 14. By Region - Global Clinical Trials Revenue Market Share, 2018-2029
Figure 15. By Country - North America Clinical Trials Revenue Market Share, 2018-2029
Figure 16. US Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Clinical Trials Revenue Market Share, 2018-2029
Figure 20. Germany Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 21. France Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Clinical Trials Revenue Market Share, 2018-2029
Figure 28. China Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 32. India Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Clinical Trials Revenue Market Share, 2018-2029
Figure 34. Brazil Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Clinical Trials Revenue Market Share, 2018-2029
Figure 37. Turkey Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 41. Quintiles IMS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Paraxel International Corporation Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Charles River Laboratories Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ICON plc Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. SGS SA Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pharmaceutical Product Development, LLC Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Wuxi AppTec Inc. Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. PRA Health Sciences Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Chiltern International Ltd. Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. INC Research Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)